As of 2024-12-12, the Intrinsic Value of Abivax SA (ABVX.PA) is
-14.01 EUR. This ABVX.PA valuation is based on the model Peter Lynch Fair Value.
With the current market price of 7.95 EUR, the upside of Abivax SA is
-276.18%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-14.01 EUR
Intrinsic Value
ABVX.PA Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-14.01 - -14.01 |
-14.01 |
-276.18% |
| P/E |
(33.78) - (29.64) |
(32.78) |
-512.3% |
| DDM - Stable |
(29.06) - (130.18) |
(79.62) |
-1101.6% |
| DDM - Multi |
(0.39) - (1.32) |
(0.60) |
-107.6% |
ABVX.PA Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
503.52 |
| Beta |
1.35 |
| Outstanding shares (mil) |
63.34 |
| Enterprise Value (mil) |
377.93 |
| Market risk premium |
5.82% |
| Cost of Equity |
8.34% |
| Cost of Debt |
5.00% |
| WACC |
7.98% |